Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis

M Fujii, T Karumai, R Yamamoto… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction: Antimicrobial dose optimization for the treatment of sepsis remains challenging
because of dynamic pharmacokinetic alterations and physiological/pathological responses …
被引用次数：26 相关文章

Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis.

M Fujii, T Karumai, R Yamamoto… - Expert Opinion on …, 2020 - europepmc.org
Introduction: Antimicrobial dose optimization for the treatment of sepsis remains challenging
because of dynamic pharmacokinetic alterations and physiological/pathological responses …

[引用][C] Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis

M Fujii, T Karumai, R Yamamoto… - Expert Opinion on …, 2020 - espace.library.uq.edu.au
Introduction: Antimicrobial dose optimization for the treatment of sepsis remains challenging
because of dynamic pharmacokinetic alterations and physiological/pathological responses …

Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis

M Fujii, T Karumai, R Yamamoto… - Expert opinion on …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction: Antimicrobial dose optimization for the treatment of sepsis remains challenging
because of dynamic pharmacokinetic alterations and physiological/pathological responses …